Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment.
Ottaiano A, Santorsola M, Ianniello M, Ceccarelli A, Casillo M, Sabbatino F, Petrillo N, Cascella M, Caraglia F, Picone C, Perri F, Sirica R, Zappavigna S, Nasti G, Savarese G, Caraglia M. Ottaiano A, et al. Among authors: sabbatino f. J Transl Med. 2024 Apr 22;22(1):379. doi: 10.1186/s12967-024-05184-w. J Transl Med. 2024. PMID: 38650006 Free PMC article.
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival.
Ottaiano A, Santorsola M, Circelli L, Perri F, Cascella M, Sabbatino F, Capuozzo M, Granata V, Zappavigna S, Lombardi A, Scrima M, Petrillo N, Ianniello M, Casillo M, Gualillo O, Nasti G, Caraglia M, Savarese G. Ottaiano A, et al. Among authors: sabbatino f. Front Med (Lausanne). 2023 Jan 23;10:1091634. doi: 10.3389/fmed.2023.1091634. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36756182 Free PMC article.
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis.
Ottaiano A, Santorsola M, Capuozzo M, Perri F, Circelli L, Cascella M, Ianniello M, Sabbatino F, Granata V, Izzo F, Iervolino D, Casillo M, Petrillo N, Gualillo O, Nasti G, Savarese G. Ottaiano A, et al. Among authors: sabbatino f. Crit Rev Oncol Hematol. 2023 Jun;186:104018. doi: 10.1016/j.critrevonc.2023.104018. Epub 2023 May 5. Crit Rev Oncol Hematol. 2023. PMID: 37150312 Free article. Review.
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer.
Ottaiano A, Santorsola M, Circelli L, Ianniello M, Casillo M, Petrillo N, Sabbatino F, Cascella M, Perri F, Capuozzo M, Albino V, Granata V, Izzo F, Di Mauro A, Berretta M, Ruggiero R, Gualillo O, Sirica R, Nasti G, Savarese G. Ottaiano A, et al. Among authors: sabbatino f. Neoplasia. 2023 Oct;44:100930. doi: 10.1016/j.neo.2023.100930. Epub 2023 Aug 25. Neoplasia. 2023. PMID: 37634281 Free PMC article. No abstract available.
Two-year Opioid Prescription Trends in Local Sanitary Agency Naples 3 South, Campania Region, Italy. Descriptive Analyses and AI-based Translational Perspectives.
Cascella M, Capuozzo M, Ferrara F, Ottaiano A, Perri F, Sabbatino F, Conti V, Santoriello V, Ponsiglione AM, Romano M, Amato F, Piazza O. Cascella M, et al. Among authors: sabbatino f. Transl Med UniSa. 2024 Feb 27;26(1):1-14. doi: 10.37825/2239-9747.1047. eCollection 2024. Transl Med UniSa. 2024. PMID: 38560616 Free PMC article.
Emerging treatment approaches for triple-negative breast cancer.
Capuozzo M, Celotto V, Santorsola M, Fabozzi A, Landi L, Ferrara F, Borzacchiello A, Granata V, Sabbatino F, Savarese G, Cascella M, Perri F, Ottaiano A. Capuozzo M, et al. Among authors: sabbatino f. Med Oncol. 2023 Dec 1;41(1):5. doi: 10.1007/s12032-023-02257-6. Med Oncol. 2023. PMID: 38038783 Review.
Beyond Body Size: Adiponectin as a Key Player in Obesity-Driven Cancers.
Capuozzo M, Celotto V, Landi L, Ferrara F, Sabbatino F, Perri F, Cascella M, Granata V, Santorsola M, Ottaiano A. Capuozzo M, et al. Among authors: sabbatino f. Nutr Cancer. 2023;75(10):1848-1862. doi: 10.1080/01635581.2023.2272343. Epub 2023 Nov 30. Nutr Cancer. 2023. PMID: 37873648 Review.
Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review.
Conti V, Bertini N, Ricciardi R, Stefanelli B, De Bellis E, Sellitto C, Cascella M, Sabbatino F, Corbi G, Pagliano P, Filippelli A. Conti V, et al. Among authors: sabbatino f. Expert Opin Drug Metab Toxicol. 2024 Apr;20(4):275-292. doi: 10.1080/17425255.2024.2339397. Epub 2024 Apr 5. Expert Opin Drug Metab Toxicol. 2024. PMID: 38568077
87 results